MARSHALL WACE, LLP - IMMUNOGEN INC ownership

IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 218 filers reported holding IMMUNOGEN INC in Q1 2019. The put-call ratio across all filers is 0.63 and the average weighting 0.0%.

Quarter-by-quarter ownership
MARSHALL WACE, LLP ownership history of IMMUNOGEN INC
ValueSharesWeighting
Q1 2023$439,123
-61.2%
114,355
-49.9%
0.00%
-66.7%
Q4 2022$1,132,938
+0.3%
228,415
-3.3%
0.00%
+50.0%
Q3 2022$1,129,000
-73.4%
236,200
-54.8%
0.00%
-89.5%
Q1 2021$4,237,000
+609.7%
523,087
+199.0%
0.02%
+216.7%
Q1 2020$597,000
+2.6%
174,919
+53.5%
0.01%
+50.0%
Q4 2019$582,000
+85.4%
113,932
-21.2%
0.00%
+33.3%
Q2 2019$314,000
-75.0%
144,493
-44.8%
0.00%
-76.9%
Q4 2018$1,256,000261,6080.01%
Other shareholders
IMMUNOGEN INC shareholders Q1 2019
NameSharesValueWeighting ↓
Redmile Group, LLC 13,063,767$35,403,0001.04%
QVT Financial LP 1,375,900$3,442,0000.87%
Virtus ETF Advisers LLC 50,045$136,0000.29%
Fernwood Investment Management, LLC 187,000$507,0000.27%
PURA VIDA INVESTMENTS, LLC 524,600$1,422,0000.20%
Endurant Capital Management LP 184,440$500,0000.20%
Birchview Capital, LP 90,000$244,0000.15%
TWIN FOCUS CAPITAL PARTNERS, LLC 112,873$306,0000.14%
DLD Asset Management, LP 1,239,500$3,347,0000.12%
DLD Asset Management, LP 1,186,300$3,215,0000.12%
View complete list of IMMUNOGEN INC shareholders